Pfizer, Moderna seen reaping billions from COVID-19 vaccine booster market

By Michael Erman NEW YORK, Aug 13 (Reuters) – Drugmakers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID-19 booster shots in a market that could rival the $6 billion in annual sales for flu vaccines for years to come, analysts and healthcare investors say.